[1] |
SU Lingfeng, WANG Huxia, WANG Yanfeng, SONG Zhangjun.
Impact of chronic stress on the development of breast cancer
[J]. Basic & Clinical Medicine, 2024, 44(9): 1303-1307.
|
[2] |
XIA Yujia, YANG Zhenli, DAI Di, LIU Yuqin.
Culture and characterization of breast cancer organoids
[J]. Basic & Clinical Medicine, 2024, 44(9): 1223-1228.
|
[3] |
ZHOU Changdong, LIN Yang, SUN Kai, TIAN Yuxin.
Knockdown of lncRNA UCA1 reduces gemcitabine resistance of human bladder cancer cell line T24
[J]. Basic & Clinical Medicine, 2024, 44(8): 1113-1119.
|
[4] |
LU Kai, LU Jianju, GUO Wenli, HUANG Jianqi, LI Zhihua.
lncRNA VIM-AS5 expression and its effect on proliferation and migration of human breast cancer cell lines
[J]. Basic & Clinical Medicine, 2024, 44(4): 447-453.
|
[5] |
NAN Lu, GUO Menjie, GAO Yanan, JIA Hongyan.
Research progress on the mechanism of annexin A family members in breast cancer
[J]. Basic & Clinical Medicine, 2024, 44(3): 393-397.
|
[6] |
Yiheliman·MAIMAITI, CAO Yanzhen, WANG Cuicui, YUE Na, LIANG Liping.
Correlation between PIK3CA mutation and clinicopathological features and prognosis of breast cancer
[J]. Basic & Clinical Medicine, 2024, 44(3): 303-307.
|
[7] |
LI Jiangli, SUN Jing, TANG Yijun, GUO Junlan, CHEN Bo, GUO Shengnan.
Circ-DDX5 inhibits the proliferation and invasion of human breast cancer cell lines by targeting miR-3940
[J]. Basic & Clinical Medicine, 2024, 44(1): 1-7.
|
[8] |
ZHANG Liangliang, ZHAO Chengjin, ZHOU Yuhu, CAO Bo, DUAN Mingming, FENG Yangyang.
LncRNA FGD5-AS1 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells by regulating miR-93-5p/BMP2 axis
[J]. Basic & Clinical Medicine, 2023, 43(8): 1179-1185.
|
[9] |
CHEN Ning, PENG Tianying, ZHANG Weimiao, GAO Yanuo, LI Xuan, YAN Caizhen, LI Junxia.
Synergistic pro-apoptotic effect of triptolide combined with doxorubicin in human breast cancer cell line MCF-7
[J]. Basic & Clinical Medicine, 2023, 43(8): 1186-1192.
|
[10] |
WANG Jihui, CAO Jilie, ZHANG Lijun, ZHANG Jun, LU Wenbao.
TARBP2 promotes human breast cancer cell metastasis by degrading AKAP12 transcript
[J]. Basic & Clinical Medicine, 2023, 43(8): 1259-1264.
|
[11] |
TANG Yijun, WANG Wenlong, LI Jiangli, YANG Huan, SUN Jing.
LncRNA RP11-686D22.10 is related with the survival of breast cancer patients, affects the proliferation, invasion of breast cancer cell lines
[J]. Basic & Clinical Medicine, 2023, 43(7): 1023-1029.
|
[12] |
ZHANG Yongmei, ZHANG Zhiming, ZHOU Jie, PAN Zhilan, FENG Liqian, YANG Yan.
Expression and clinical significance of LncRNA CBR3-AS1 in multiple myeloma
[J]. Basic & Clinical Medicine, 2023, 43(6): 948-952.
|
[13] |
YAO Liuxu, LI Yuhong, JIANG Zongming.
Research progress of exosome lncRNA in liquid biopsy of colorectal cancer
[J]. Basic & Clinical Medicine, 2023, 43(2): 317-321.
|
[14] |
YANG Liangquan, YU Miao, JIANG Qian, ZHANG Minghui, YANG Haisong.
miR-504 regulates proteasome activator and inhibits the proliferation and migration of breast cancer cell line MCF-7
[J]. Basic & Clinical Medicine, 2023, 43(1): 95-101.
|
[15] |
YANG Guanglin, REN Lijuan, CHEN Wenjing, XIONG Weijun.
LncRNA MINCR inhibits LPS-induced damage and inflammation of alveolar epithelial cell line A549 by targeting at miR-223
[J]. Basic & Clinical Medicine, 2023, 43(1): 102-109.
|